Nanochon Chondrograft First in Human Early Feasibility Study - Panama

NIH registered a new clinical trial on ClinicalTrials.gov for the Nanochon Chondrograft Implant, a device under early feasibility evaluation as a primary surgical treatment for knee cartilage lesions. The study will enroll adult participants between ages 22 and 60 in Panama.

Affected parties include clinical investigators and sponsors conducting device trials in the knee cartilage space. This registry entry is informational and does not itself impose compliance obligations, though it signals ongoing clinical activity in cartilage repair devices.